AN2 Therapeutics (ANTX) Amortizatization of Intangibles (2021 - 2026)

AN2 Therapeutics (ANTX) has 6 years of Amortizatization of Intangibles data on file, last reported at $81000.0 in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 81.72% year-over-year to $81000.0 in Q1 2026; TTM through Mar 2026 was $708000.0, a 73.09% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 67.37% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $81000.0, down from $117000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for ANTX reached as high as $1.3 million in Q4 2023 and fell as low as -$1000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $469235.3 across 5 years, with a median of $435000.0 in 2023.
• Across the five-year window, Amortizatization of Intangibles jumped 43600.0% in 2023 and plunged 81.72% in 2026, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $375000.0 in 2022, then soared by 248.27% to $1.3 million in 2023, then sank by 56.58% to $567000.0 in 2024, then tumbled by 79.37% to $117000.0 in 2025, then tumbled by 30.77% to $81000.0 in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $81000.0 in Q1 2026, $117000.0 in Q4 2025, and $211000.0 in Q3 2025.